Adam Giermasz
- Oncology top 10%
- Molecular Biology
- Hematology top 5%
- Genetics top 10%
- Cancer Research top 10%
- Co-authors
- Marek JakóbisiakWojciech FeleszkoTomasz StokłosaAnna CzajkaJakub GołąbWitold LasekRadosław ZagożdżonTomasz Świtaj
- Topics
- Hemophilia Treatment and Research (16 papers)Virus-based gene therapy research (14 papers)Immunotherapy and Immune Responses (14 papers)
- Cited by
- HematologyOncologyCancer Research
- Partner nations
- PolandUnited StatesGermany
In The Last Decade
Adam Giermasz
54 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 78
- Oncology 401
- Molecular Biology 387
- Hematology 267
- Genetics 263
- Cancer Research 216
Countries citing papers authored by Adam Giermasz
This map shows the geographic impact of Adam Giermasz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Giermasz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Giermasz more than expected).
Fields of papers citing papers by Adam Giermasz
This network shows the impact of papers produced by Adam Giermasz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Giermasz. The network helps show where Adam Giermasz may publish in the future.
Co-authorship network of co-authors of Adam Giermasz
This figure shows the co-authorship network connecting the top 25 collaborators of Adam Giermasz. A scholar is included among the top collaborators of Adam Giermasz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Giermasz. Adam Giermasz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 16 | |
| 6 | 21 | |
| 7 | 21 | |
| 8 | 52 | |
| 9 | 4 | |
| 10 | 10 | |
| 11 | 13 | |
| 12 | 12 | |
| 13 | 32 | |
| 14 | 6 | |
| 15 | 24 | |
| 16 | 6 | |
| 17 | 17 | |
| 18 | 4 | |
| 19 | 22 | |
| 20 | 29 |
About Adam Giermasz
Adam Giermasz is a scholar working on Hematology, Immunology and Oncology, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (16 papers), Virus-based gene therapy research (14 papers) and Immunotherapy and Immune Responses (14 papers). The work is most often cited by research in Hematology (267 citations), Oncology (401 citations) and Cancer Research (216 citations). Adam Giermasz has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Marek Jakóbisiak, Wojciech Feleszko, Tomasz Stokłosa, Anna Czajka, Jakub Gołąb, Witold Lasek, Radosław Zagożdżon, Tomasz Świtaj, Izabela Młynarczuk-Biały and Anna Dąbrowska‐Iwanicka. Their work appears in journals such as New England Journal of Medicine, Blood and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.